Return to content in this issue

 

Subcutaneous C1 inhibitor for the long-term prophylaxis of hereditary angioedema -a real life experience

Baynova K1, Cimbollek S1, Quiralte J1, García R1, Lucena JM2, Lasa Luaces E3, Lara Jiménez MA4, Alvarez Nieto J5, Moreto J6, González-Quevedo T1

1National Angioedema Reference Unit, Allergology Department, Virgen del Rocío University Hospital. Avenida Manuel Siurot, s/n, 41013 Seville, Spain.
2Immunology Department, Virgen del Rocío University Hospital. Avenida Manuel Siurot, s/n, 41013 Seville, Spain.
3Pediatric Allergology Unit, Allergology Department, Donostia University Hospital. Begiristain Doktorea Pasealekua, s/n, 20014 Donostia, Spain.
4Allergology Unit, San Cecilio University Hospital, Av. del Conocimiento, s/n, 18016 Granada, Spain.
5CSL Behring España S.A. Calle Tarragona, 157, 18th floor, 08014 Barcelona, Spain.
6Ampersand Consulting. Calle Muntaner, 140, Pral, 2a, 08036 Barcelona, Spain.

J Investig Allergol Clin Immunol 2024; Vol. 34(3)
doi: 10.18176/jiaci.0948

Key words: Hereditary angioedema,C1 esterase inhibitor, Subcutaneous replacement therapy